Bioluminescence Resonance Energy Transfer (BRET) Imaging in Living Cells: Image Acquisition and Quantification.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2021
Historique:
entrez: 29 5 2021
pubmed: 30 5 2021
medline: 22 6 2021
Statut: ppublish

Résumé

Bioluminescence resonance energy transfer (BRET) is an energy transfer phenomenon from a luciferase donor to a fluorescence acceptor and serves as an indicator of protein-protein interaction or protein proximity. BRET imaging is a powerful tool in the investigation of signaling proteins because it enables spatial analysis of such protein interactions. Here, we describe a method exerting high-resolution BRET imaging by combining bright-light output luciferases, such as NanoLuc , photon-counting EM-CCD, and unique algorithms for image correction and denoising.

Identifiants

pubmed: 34050482
doi: 10.1007/978-1-0716-1258-3_26
doi:

Substances chimiques

Luminescent Agents 0
Luciferases EC 1.13.12.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

305-314

Références

Galés C, Rebois RV, Hogue M et al (2005) Real-time monitoring of receptor and G protein interactions in living cells. Nat Methods 2:177–184
Kobayashi H, Ogawa K, Yao R et al (2009) Functional rescue of beta-adrenoceptor dimerization and trafficking by pharmacological chaperones. Traffic 10:1019–1033
doi: 10.1111/j.1600-0854.2009.00932.x
Mercier J-F, Salahpour A, Angers S et al (2002) Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem 277:44925–44931
doi: 10.1074/jbc.M205767200
Terrillon S, Barberis C, Bouvier M (2004) Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns. Proc Natl Acad Sci U S A 101:1548–1553
Héroux M, Breton B, Hogue M et al (2007) Assembly and signaling of CRLR and RAMP1 complexes assessed by BRET. Biochemistry 46:7022–7033
doi: 10.1021/bi0622470
Namkung Y, le Gouill C, Lukashova V et al (2016) Monitoring G protein-coupled receptor and β-arrestin trafficking in live cells using enhanced bystander BRET. Nat Commun 7:12178
doi: 10.1038/ncomms12178
Kobayashi H, Picard L-P, Schönegge A-M et al (2019) Bioluminescence resonance energy transfer-based imaging of protein-protein interactions in living Cells. Nat Protocols 14:1084–1107
Azzari L, Foi A (2016) Variance stabilization for noisy+estimate combination in iterative poisson denoising. IEEE Signal Proc Lett 23:1086–1090
doi: 10.1109/LSP.2016.2580600
Hall MP, Unch J, Binkowski BF et al (2012) Engineered luciferase reporter from a deep-sea shrimp utilizing a novel imidazopyrazinone substrate. ACS Chem Biol 7:1848–1857
doi: 10.1021/cb3002478
Goyet E, Bouquier N, Ollendorff V et al (2016) Fast- and high-resolution single-cell BRET imaging. Sci Rep 6:28231
doi: 10.1038/srep28231
Xu X, Soutto M, Xie Q et al (2007) Imaging protein interactions with bioluminescence resonance energy transfer (BRET) in plant and mammalian cells and tissues. Proc Natl Acad Sci U S A 104:10264–10269
doi: 10.1073/pnas.0701987104
Nguyen AW, Daugherty PS (2005) Evolutionary optimization of fluorescent proteins for intracellular FRET. Nat Biotechnol 23:355–360
doi: 10.1038/nbt1066
Chu J, Oh Y, Sens A et al (2016) A bright cyan-excitable orange fluorescent protein facilitates dual-emission microscopy and enhances bioluminescence imaging In Vivo. Nat Biotechnol 34:760–767
doi: 10.1038/nbt.3550
Basden AG, Haniff CA, Mackay CD (2003) Photon-counting strategies with low-light-level CCDs. Mon Not Roy Astron Soc 345:985–991
doi: 10.1046/j.1365-8711.2003.07020.x

Auteurs

Hiroyuki Kobayashi (H)

Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, Canada.

Michel Bouvier (M)

Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, Canada. michel.bouvier@umontreal.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH